Synthesis and antimalarial bioassay of quinine - peptide conjugates

Chemical Biology and Drug Design

Volumn 82, Issue 4, 2013, Pages 361-366

  Panda, Siva S ^a   Ibrahim, Mohamed A ^a,b,c   Küçükbay, Hasan ^a,d   Meyers, Marvin J ^e   Sverdrup, Francis M ^e   El Feky, Said A ^c   Katritzky, Alan R ^a,f  

^a University of Florida   (United States)

^b Misr University for Science and Technology   (Egypt)

^c Zagazig University   (Egypt)

^d INONU UNIVERSITY   (Turkey)

^e SAINT LOUIS UNIVERSITY   (United States)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Amino acid; Chemical biology; Drug design; Peptide

Indexed keywords

(6 METHOXYQUINOLIN 4 YL)(5 VINYLQUINUCLIDIN 2 YL)METHYL 2 ((TERT BUTOXYCARBONYL)AMINO) 3 (1 TOSYL 1H IMIDAZOL 4 YL)PROPANOATE; (6 METHOXYQUINOLIN 4 YL)(5 VINYLQUINUCLIDIN 2 YL)METHYL 3 (BENZYLOXY) 2 ((TERT BUTOXYCABONYL)AMINO)PROPANOATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL 2 2 (((BENZYLOXY) 2 CARBONYL)AMINOL)PROPANAMIDO) 3 PHENYLPROPANOATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL 2 2 (((BENZYLOXY)CABONYL)AMINO) 3 METHYL PENTANAMIDO)ACETATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL 2 2 (((BENZYLOXY)CARBONYL)AMINO) 3 METHYL BUTANAMIDO) 4 METHYLPENTANOATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL 2,6 BIS(((BENZYLOXY)CABONYL)AMINO)HEXANOATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL 8 BENZYL 11 METHYL 3,6,9 TRIOXO 1 PHENYL 2 OXA 4,7,10 TRIAZADODECAN 12 OATE; (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL) 2 (((BENZYLOXY)CABONYL)AMINO)SUCCINATE; (6 METHOXYQUINOLIN 4 YL)(8 VINYLQUINUCLIDIN 2 YL)METHYL) 2 (BENZYLAMINO) 3 (BENZYLTHIOL)PROPANOATE; 5 BENZYL 1 (6 METHOXYQUINOLIN 4 YL)(6 VINYLQUINUCLIDIN 2 YL)METHYL) 2 ((TERT BUTOXYCABONYL)AMINO)PENTANEDIOATE; AMINO ACID; ANTIMALARIAL AGENT; BENZOTRIAZOLE DERIVATIVE; PEPTIDE; QUININE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOASSAY; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DETERMINATION; DRUG SYNTHESIS; IC 50; IN VITRO STUDY; MICROWAVE IRRADIATION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID; CHEMICAL BIOLOGY; DRUG DESIGN; PEPTIDE;

ANTIMALARIALS; BIOLOGICAL ASSAY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PEPTIDES; QUININE;

EID: 84884819181     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12134     Document Type: Article

References (22)

1. Meshnick S., Dobson M. (2001) Antimalarial chemotherapy. In: Rosenthal P., editor. Mechanism of Action, Resistance and New Directions in Drug Discovery. Totowa, NJ, USA: Humana; p. 15-26.
2. Daily J.P. (2006) Antimalarial drug therapy: the role of parasite biology and drug resistance. J Clin Pharmacol;46:1487-1497.
3. Kumar V., Mahajan A., Chibale K. (2009) Synthetic medicinal chemistry of selected antimalarial natural products. Bioorg Med Chem;17:2236-2275.
4. Dinio T., Gorka A., McGinniss A., Roepe P.D., Morgan J.B. (2012) Investigating the activity of quinine analogues versus chloroquine resistant Plasmodium falciparum. Bioorg Med Chem;20:3292-3297.
5. Philip A., Kepler J.A., Johnson B.H., Carroll F.I. (1988) Peptide derivatives of primaquine as potential antimalarial agents. J Med Chem;31:870-874.
6. Rennert R., Neundorf I., Beck-Sickinger A.G. (2009) Nucleic acid and peptide aptamers. In: Methods in Molecular Biology, vol. 535, ch. 22. New York, NY, USA: Humana; p. 389-403.
7. Tai W., Shukla R.S., Qin B., Li B., Cheng K. (2011) Development of a peptide-drug conjugate for prostate cancer therapy. Mol Pharm;8:901-912.
8. Mazel M., Clair P., Rousselle C., Vidal P., Scherrmann J.M., Mathieu D., Temsamani J. (2001) Doxorubicin-peptide conjugates overcome multidrug resistance. Anticancer Drugs;12:107-116.
9. Langer M., Kratz F., Rothen-Rutishauser B., Wunderli-Allenspach H., Beck-Sickinger A.G. (2001) Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem;44:1341-1348.
10. Khozoie C., Pleass R.J., Avery S.V. (2009) The antimalarial drug quinine disrupts Tat2p-mediated tryptophan transport and causes tryptophan starvation. J Biol Chem;284:17968-17974.
11. Islahudin F., Pleass R.J., Avery S.V., Ting K. (2012) Quinine interactions with tryptophan and tyrosine in malaria patients, and implications for quinine responses in the clinical setting. J Antimicrob Chemother;67:2501-2505.
12. Gordon K.D., Caprio J. (1985) Taste responses to amino acids in the southern leopard frog, Rana sphenocephala. Comp Biochem Physiol;81A:525-530.
13. Bajaj K., Panda S.S., El-Nachef C., Katritzky A.R. (2012) Syntheses of chiral N-(protected) tri- and tetrapeptide conjugates. Chem Biol Drug Des;80:17-26.
14. Panda S.S., Bajaj K., Meyers M.J., Sverdrup F.M., Katritzky A.R. (2012) Quinine bis-conjugates with quinolone antibiotics and peptides: synthesis and antimalarial bioassay. Org Biomol Chem;10:8985-8993.
15. Larhed M., Moberg C., Hallberg A. (2002) Microwave-accelerated homogeneous catalysis in organic chemistry. Acc Chem Res;35:717-727.
16. Trager W., Jensen J.B. (1976) Human malaria parasites in continuous culture. Science;193:673-675.
17. Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., Riscoe M.K. (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother;48:1803-1806.
18. Winter R.W., Kelly J.X., Smilkstein M.J., Dodean R., Bagby G.C., Rathbun R.K., Levin J.I., Hinrichs D., Riscoe M.K. (2006) Evaluation and lead optimization of antimalarial acridones. Exp Parasitol;114:47-56.
19. Panda S.S., El-Nachef C., Bajaj K., Al-Youbi A.O., Oliferenko A., Katritzky A.R. (2012) Study of chemical ligation via 17-, 18- and 19-membered cyclic transition states. Chem Biol Drug Des;80:821-827.
20. Katritzky A.R., Angrish P., Todadze E. (2009) Chiral acylation with N-(protected α-aminoacyl)benzotriazoles for advantageous syntheses of peptides and peptide conjugates. Synlett;15:2392-2411.
21. Bajaj K., Panda S.S., Ibrahim M.A., El-Feky S.A., Katritzky A.R. (2013) Introduction of histidine units using benzotriazolide activation. J Pept Sci;19:110-117.
22. Weygand F., Prox A., Koenig W. (1966) Racemization of the penultimate amino acid with a terminal carboxyl group in peptide syntheses. Chem Ber;99:446-1450.